Clinical Trials Browser

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT05118724 2025-06-15

ANTONIO

Phase 2 Active not recruiting

80 enrolled

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT06646445 2025-06-13

PREMICES

Phase 2 Not yet recruiting

60 enrolled

Gastrointestinal

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT02983578 2025-05-06

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

Phase 2 Active not recruiting

39 enrolled

GastrointestinalThoracic

Turcot syndrome, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05371197 2022-05-12

Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer

Phase 2 Unknown

26 enrolled

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT04001101 2021-11-30

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Phase 2 Withdrawn

Gastrointestinal

Turcot syndrome, Neoplasm Metastasis, Colorectal Neoplasms

NCT03150706 2020-04-03

Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer

Phase 2 Unknown

33 enrolled

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms